| Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa A Boulle, G Van Cutsem, K Hilderbrand, C Cragg, M Abrahams, S Mathee, ... Aids 24 (4), 563-572, 2010 | 333 | 2010 |
| Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial MX Rangaka, RJ Wilkinson, A Boulle, JR Glynn, K Fielding, ... The Lancet 384 (9944), 682-690, 2014 | 306 | 2014 |
| Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007 M Cornell, A Grimsrud, L Fairall, MP Fox, G van Cutsem, J Giddy, R Wood, ... Aids 24 (14), 2263-2270, 2010 | 283 | 2010 |
| Effect of HIV-1 infection on T-cell–based and skin test detection of tuberculosis infection MX Rangaka, KA Wilkinson, R Seldon, G Van Cutsem, GA Meintjes, ... American journal of respiratory and critical care medicine 175 (5), 514-520, 2007 | 280 | 2007 |
| Outcomes of nevirapine-and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy A Boulle, G Van Cutsem, K Cohen, K Hilderbrand, S Mathee, M Abrahams, ... Jama 300 (5), 530-539, 2008 | 279 | 2008 |
| Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South Africa MA Luque-Fernandez, G Van Cutsem, E Goemaere, K Hilderbrand, ... PloS one 8 (2), e56088, 2013 | 244 | 2013 |
| Community‐supported models of care for people on HIV treatment in sub‐S aharan A frica M Bemelmans, S Baert, E Goemaere, L Wilkinson, M Vandendyck, ... Tropical Medicine & International Health 19 (8), 968-977, 2014 | 222 | 2014 |
| Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa D Coetzee, A Boulle, K Hildebrand, V Asselman, G Van Cutsem, ... Aids 18, S27-S31, 2004 | 197 | 2004 |
| Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa MP Fox, G Van Cutsem, J Giddy, M Maskew, O Keiser, H Prozesky, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 60 (4), 428-437, 2012 | 179 | 2012 |
| Type 1 helper T cells and FoxP3-positive T cells in HIV–tuberculosis-associated immune reconstitution inflammatory syndrome G Meintjes, KA Wilkinson, MX Rangaka, K Skolimowska, K Van Veen, ... American journal of respiratory and critical care medicine 178 (10), 1083-1089, 2008 | 175 | 2008 |
| Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort A Boulle, C Orrell, R Kaplan, G Van Cutsem, M McNally, K Hilderbrand, ... Antiviral therapy 12 (5), 753-760, 2007 | 167 | 2007 |
| Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa M Egger, BD Spycher, J Sidle, R Weigel, EH Geng, MP Fox, P MacPhail, ... PLoS medicine 8 (1), e1000390, 2011 | 166 | 2011 |
| Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared O Keiser, C Orrell, M Egger, R Wood, MWG Brinkhof, H Furrer, ... PLoS medicine 5 (7), e148, 2008 | 162 | 2008 |
| Outcomes of the South African national antiretroviral treatment programme for children: the IeDEA Southern Africa collaboration MA Davies, O Keiser, B Eley, H Rabie, G van Cutsem, J Giddy, R Wood, ... South African medical journal 99 (10), 2009 | 159 | 2009 |
| Virologic failure and second-line antiretroviral therapy in children in South Africa—the IeDEA Southern Africa collaboration MA Davies, H Moultrie, B Eley, H Rabie, G Van Cutsem, J Giddy, R Wood, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 56 (3), 270-278, 2011 | 148 | 2011 |
| Community-based interventions to improve and sustain antiretroviral therapy adherence, retention in HIV care and clinical outcomes in low-and middle-income countries for … JB Nachega, O Adetokunboh, OA Uthman, AW Knowlton, FL Altice, ... Current HIV/AIDS Reports 13, 241-255, 2016 | 140 | 2016 |
| Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa HS Cox, C McDermid, V Azevedo, O Muller, D Coetzee, J Simpson, ... PLoS One 5 (11), e13901, 2010 | 130 | 2010 |
| Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa H Cox, J Hughes, J Daniels, V Azevedo, C McDermid, M Poolman, ... The International Journal of Tuberculosis and Lung Disease 18 (4), 441-448, 2014 | 127 | 2014 |
| Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysis G Van Cutsem, N Ford, K Hildebrand, E Goemaere, S Mathee, ... PLoS One 6 (2), e14684, 2011 | 126 | 2011 |
| Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa L Fenner, MWG Brinkhof, O Keiser, R Weigel, M Cornell, H Moultrie, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 54 (5), 524-532, 2010 | 121 | 2010 |
Andrew BoulleSchool of Public Health and Family Medicine, University of Cape TownVerified email at uct.ac.za
